Nature Communications · 7 July 2026 · From issue 03
Anti-PD-1 plus anti-CTLA-4 blockade overcomes immune exclusion in NSCLC brain metastases by enhancing CD8+ T cell responses and promoting tertiary lymphoid structure formation
Combining two immune drugs worked better than one drug against lung cancer that spread to the brain.
Kazutaka Hosoya, Hiroaki Ozasa et al.
Integrity screen: passed (3 checks) Checked 8 July 2026. Read the source
The plain-language reading of this paper is in the full issue, for subscribers.
Read the full issue